Vanguard Announces Cash Distributions For The Vanguard ETFs-March 2024-www.financetom.com

Vanguard Announces Cash Distributions For The Vanguard ETFs

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Vanguard Announces Cash Distributions For The Vanguard ETFs

Apr 25, 2024 1:14 PM

03:53 PM EDT, 04/25/2024 (MT Newswires) -- Vanguard Investments Canada Thursday announced the final April 2024 cash distributions for certain Vanguard ETFs that trade on Toronto Stock Exchange (TSX).

Unitholders of record on May 02, 2024 will receive cash distributions payable on May 09, 2024.

Those ETF distributions per unit include: (VAB) C$0.068312; (VSB) C$0.054814; (VSC) C$0.075609; (VLB) C$0.075210; (VCB) C$0.084123; and (VGV) C$0.059646.

Vanguard Investments Canada manages $C63 billion in assets (as of Dec. 31, 2023) with 37 Canadian ETFs and six mutual funds currently available.

Price: 22.01, Change: -0.05, Percent Change: -0.23

Previous page： BTG Pactual's Andre Esteves expected to join Eneva's board Next page： Why Is Milestone Pharmaceuticals Stock Plunging Today?

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

BTG Pactual's Andre Esteves expected to join Eneva's board

Mar 28, 2025

SAO PAULO, March 28 (Reuters) - The chairman of Brazil's investment bank BTG Pactual, billionaire Andre Esteves, is expected to join the board of power generator Eneva , according to a proposal released on Friday for Eneva's shareholders' meeting. Under the proposal, Eneva's board of directors, composed of seven members, would see two new members as two others exit. Rodrigo...

Why Is Milestone Pharmaceuticals Stock Plunging Today?

Mar 28, 2025

Milestone Pharmaceuticals Inc. ( MIST ) announced on Friday that its New Drug Application for CARDAMYST (etripamil) nasal spray, aimed at treating acute episodes of paroxysmal supraventricular tachycardia, received a Complete Response Letter from the U.S. Food and Drug Administration (FDA). The company’s shares are trading lower following the news. While the FDA did not raise concerns about the clinical...

PTC Therapeutics Loses EU Authorization for Translarna in Duchenne Muscular Dystrophy

Mar 28, 2025

09:52 AM EDT, 03/28/2025 (MT Newswires) -- PTC Therapeutics ( PTCT ) said Friday that the European Commission has adopted the recommendation of the Committee for Medicinal Products for Human Use to not renew Translarna's marketing authorization for nonsense mutation Duchenne muscular dystrophy. The commission indicated that under EU Directive 2001/83, individual member states in the European Union can still...

Knightscope Launches $1.7 Million Registered Direct Offering

Mar 28, 2025

09:52 AM EDT, 03/28/2025 (MT Newswires) -- Knightscope ( KSCP ) said Friday it has launched a registered direct offering of 625,000 common shares at $2.75 apiece to raise about $1.7 million in gross proceeds. The offering will likely be completed around March 31, the company said. Knightscope ( KSCP ) also said it plans to allocate the net proceeds...